Novo Nordisk
NVO
NVO
510 hedge funds and large institutions have $7.76B invested in Novo Nordisk in 2016 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 190 increasing their positions, 186 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
26% less capital invested
Capital invested by funds: $10.5B → $7.76B (-$2.76B)
42% less funds holding in top 10
Funds holding in top 10: 24 → 14 (-10)
51% less call options, than puts
Call options by funds: $14.1M | Put options by funds: $29M
Holders
510
Holding in Top 10
14
Calls
$14.1M
Puts
$29M
Top Buyers
| 1 | +$139M | |
| 2 | +$77.3M | |
| 3 | +$70.9M | |
| 4 |
Morgan Stanley
New York
|
+$58.9M |
| 5 |
Millennium Management
New York
|
+$56.7M |
Top Sellers
| 1 | -$457M | |
| 2 | -$273M | |
| 3 | -$134M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$86M |
| 5 |
Lazard Asset Management
New York
|
-$65.9M |